Atrium Mortgage Investment Corporation (TSX:AI)

Verve Therapeutics Income Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Interest and Dividend Income	93.98	97.22	97.94	77.86	63.54	64.36
Total Interest Expense	24.08	25.48	25.42	19.18	12.19	13.32
Net Interest Income	69.9	71.74	72.52	58.68	51.35	51.04
Other Revenue	0.05	0.04	0.63	0.51	0.7	0.66
Revenue Before Loan Losses	69.95	71.79	73.15	59.19	52.05	51.7
Provision for Loan Losses	11.88	13.57	11.4	0.86	1.29	3.76
Revenue	58.07	58.21	61.75	58.32	50.76	47.94
Revenue Growth (YoY)	-2.61%	-5.73%	5.88%	14.90%	5.88%	0.41%
Salaries & Employee Benefits	0.16	0.13	0.15	0.13	0.11	0.12
Cost of Services Provided	9.62	9.49	9.45	9.45	8.28	8.09
Other Operating Expenses	0.46	0.5	0.5	0.54	0.35	0.31
Total Operating Expenses	10.28	10.32	10.3	10.32	8.94	8.71
Operating Income	47.79	47.9	51.46	48	41.83	39.23
EBT Excluding Unusual Items	47.71	47.85	51.49	48.16	41.79	39.19
Pretax Income	47.71	47.85	51.49	46.33	41.79	39.19
Net Income	47.71	47.85	51.49	46.33	41.79	39.19
Net Income to Common	47.71	47.85	51.49	46.33	41.79	39.19
Net Income Growth	-3.25%	-7.06%	11.12%	10.86%	6.65%	1.61%
Shares Outstanding (Basic)	46	45	44	43	43	42
Shares Outstanding (Diluted)	55	54	54	53	50	52
Shares Change (YoY)	1.15%	0.76%	2.18%	5.61%	-3.12%	1.91%
EPS (Basic)	1.04	1.06	1.18	1.08	0.98	0.93
EPS (Diluted)	1.04	1.05	1.14	1.06	0.98	0.93
EPS Growth	-5.74%	-7.83%	7.86%	8.40%	5.63%	-3.79%
Dividend Per Share	0.910	0.902	0.900	0.900	0.900	0.900
Dividend Growth	1.11%	0.28%	-	-	-	-
Operating Margin	82.29%	82.28%	83.33%	82.31%	82.40%	81.83%
Profit Margin	82.16%	82.20%	83.38%	79.44%	82.33%	81.74%
Revenue as Reported	94.03	97.26	98.57	78.37	64.24	65.02

Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.